Tibet Weixinkang Medicine Co., Ltd. (603676) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Tibet Weixinkang Medicine Co., Ltd.

Why is Tibet Weixinkang Medicine Co., Ltd. ?

Negative results in Sep 25

OPERATING CASH FLOW(Y) Lowest at CNY 216.79 MM
ROCE(HY) Lowest at 14.76%
INVENTORY TURNOVER RATIO(HY) Lowest at 12.01 times

With ROE of 17.06%, it has a fair valuation with a 3.39 Price to Book Value

Over the past year, while the stock has generated a return of 12.40%, its profits have risen by 11.5% ; the PEG ratio of the company is 1.7
At the current price, the company has a high dividend yield of 2.9

Underperformed the market in the last 1 year

The stock has generated a return of 12.40% in the last 1 year, much lower than market (China Shanghai Composite) returns of 22.49%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Tibet Weixinkang Medicine Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Tibet Weixinkang Medicine Co., Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Tibet Weixinkang Medicine Co., Ltd.

3.04%

0.64

41.34%

China Shanghai Composite

15.17%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

12.18%

EBIT Growth (5y)

38.59%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.71

Sales to Capital Employed (avg)

0.91

Tax Ratio

10.80%

Dividend Payout Ratio

60.00%

Pledged Shares

Institutional Holding

ROCE (avg)

32.01%

ROE (avg)

12.94%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.39

EV to EBIT

17.28

EV to EBITDA

14.10

EV to Capital Employed

8.69

EV to Sales

3.25

PEG Ratio

1.73

Dividend Yield

2.94%

ROCE (Latest)

50.31%

ROE (Latest)

17.06%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

DIVIDEND PAYOUT RATIO(Y)

Highest at 174.58%

RAW MATERIAL COST(Y)

Fallen by -17.63% (YoY

-19What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 216.79 MM

ROCE(HY)

Lowest at 14.76%

INVENTORY TURNOVER RATIO(HY)

Lowest at 12.01 times

NET SALES(Q)

Lowest at CNY 273.05 MM

NET PROFIT(Q)

At CNY 30.07 MM has Fallen at -52.67%

PRE-TAX PROFIT(Q)

At CNY 50.13 MM has Fallen at -30.76%

Here's what is working for Tibet Weixinkang Medicine Co., Ltd.

Dividend Payout Ratio

Highest at 174.58%

in the last five years

MOJO Watch

Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost

Fallen by -17.63% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Tibet Weixinkang Medicine Co., Ltd.

Net Sales

Lowest at CNY 273.05 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Net Sales

At CNY 273.05 MM has Fallen at -11.94%

over average net sales of the previous four periods of CNY 310.08 MM

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Net Profit

At CNY 30.07 MM has Fallen at -52.67%

over average net sales of the previous four periods of CNY 63.54 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Inventory Turnover Ratio

Lowest at 12.01 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Operating Cash Flow

Lowest at CNY 216.79 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Pre-Tax Profit

At CNY 50.13 MM has Fallen at -30.76%

over average net sales of the previous four periods of CNY 72.41 MM

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)